Corticosteroid resistance in pulmonary neutrophilic inflammatory disorders and rationale for adjunct IL-1beta targeted therapy.
Wanderer
Alan A
AA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000818:Animals; D016207:Cytokines / Q000276:immunology; D004351:Drug Resistance / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D053583:Interleukin-1beta / Q000627:therapeutic use*; D008070:Lipopolysaccharides / Q000276:immunology; D008168:Lung / Q000166:cytology* / Q000276:immunology / Q000473:pathology; D008171:Lung Diseases / Q000276:immunology / Q000473:pathology; D051379:Mice; D009504:Neutrophils / Q000187:drug effects*
D000305:Adrenal Cortex Hormones; D016207:Cytokines; D053583:Interleukin-1beta; D008070:Lipopolysaccharides